间歇性禁食和肝脏疾病:从斋月模型的见解
Rofida Khalifa1, Khalid Al-Naamani2, Mohamed Elbadry3
1Tropical Medicine Department, Faculty of Medicine, Minia University, Minia, Egypt.
概括
斋月禁食 (RF) 通过独特的代谢和昼夜挑战影响肝脏健康. 这篇评论探讨了RF的研究.
科学领域:
- 肝病学和代谢研究.
- 探讨间歇性禁食 (IF) 和其在斋月期间的具体应用.
背景情况:
- 间歇性禁食 (IF) 显示了代谢益处,但斋月禁食 (RF) 的具体情况尚未得到充分研究,特别是在肝脏疾病方面.
- 由于长时间的干禁食和改变的饮食时间,RF提出了独特的生理要求,挑战了肝脏的适应能力.
- 肝脏在新陈代谢和炎症中的中心作用,再加上穆斯林地区肝脏疾病的高发病率,需要了解射频的影响.
研究的目的:
- 综合目前关于斋月禁食 (RF) 如何影响肝功能的证据.
- 审查RF在各种肝脏疾病中的临床影响.
- 为肝病患者提供文化敏感的禁食建议提供基础.
主要方法:
- 文献综述综合了有关斋月禁食和肝脏健康的现有研究.
- 分析射频对胰岛素敏感性和自等代谢途径的影响.
- 检查射频对肠道微生物群,基因表达和炎症的影响.
主要成果:
- 斋月禁食 (RF) 影响胰岛素敏感性,自,肠道微生物群和炎症通路.
- 射频的临床影响从代谢功能障碍相关的脂肪性肝病 (MASLD) 到肝硬化,HCC和移植后情景.
- 有证据表明,射频对肝脏健康构成明显的挑战和潜在影响.
结论:
- 需要进一步的研究,以充分阐明斋月禁食 (RF) 和肝脏生理学之间的复杂相互作用.
- 文化敏感和风险分层的禁食指南对于肝病患者来说是必不可少的.
- 了解射频的影响对于管理不同人群中的肝脏健康至关重要.
关键词:
自自是一种自的过程.马斯尔德 马斯尔德是什么意思斋月禁食斋月 斋月禁食斋月昼夜节律是指昼夜节律的节奏.我们的肠道微生物组.这是一种炎症炎症炎症炎症.胰岛素敏感性 胰岛素敏感性断断续续的禁食是一种禁食.肝病管理 肝病管理肝脏代谢 肝脏代谢更多相关视频
相关概念视频
Metabolic States of the Body: Fasting and Starvation
2.7K
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
2.7K
Metabolic States of the Body: The Postabsorptive State
1.2K
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
1.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
176
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
176
Liver Physiology
3.5K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.5K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
209
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
209
Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K


